Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.